180 related articles for article (PubMed ID: 32445760)
1. Sulforaphane protects against skeletal muscle dysfunction in spontaneous type 2 diabetic db/db mice.
Wang M; Pu D; Zhao Y; Chen J; Zhu S; Lu A; Liao Z; Sun Y; Xiao Q
Life Sci; 2020 Aug; 255():117823. PubMed ID: 32445760
[TBL] [Abstract][Full Text] [Related]
2. Sulforaphane alleviates muscular dystrophy in mdx mice by activation of Nrf2.
Sun C; Yang C; Xue R; Li S; Zhang T; Pan L; Ma X; Wang L; Li D
J Appl Physiol (1985); 2015 Jan; 118(2):224-37. PubMed ID: 25593219
[TBL] [Abstract][Full Text] [Related]
3. Protective Effects of Sulforaphane on Cognitive Impairments and AD-like Lesions in Diabetic Mice are Associated with the Upregulation of Nrf2 Transcription Activity.
Pu D; Zhao Y; Chen J; Sun Y; Lv A; Zhu S; Luo C; Zhao K; Xiao Q
Neuroscience; 2018 Jun; 381():35-45. PubMed ID: 29684505
[TBL] [Abstract][Full Text] [Related]
4. The induction of the transcription factor Nrf2 enhances the antinociceptive effects of delta-opioid receptors in diabetic mice.
McDonnell C; Leánez S; Pol O
PLoS One; 2017; 12(7):e0180998. PubMed ID: 28700700
[TBL] [Abstract][Full Text] [Related]
5. Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation.
Bai Y; Cui W; Xin Y; Miao X; Barati MT; Zhang C; Chen Q; Tan Y; Cui T; Zheng Y; Cai L
J Mol Cell Cardiol; 2013 Apr; 57():82-95. PubMed ID: 23353773
[TBL] [Abstract][Full Text] [Related]
6. Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy.
Gu J; Cheng Y; Wu H; Kong L; Wang S; Xu Z; Zhang Z; Tan Y; Keller BB; Zhou H; Wang Y; Xu Z; Cai L
Diabetes; 2017 Feb; 66(2):529-542. PubMed ID: 27903744
[TBL] [Abstract][Full Text] [Related]
7. Sulforaphane Attenuates Muscle Inflammation in Dystrophin-deficient mdx Mice via NF-E2-related Factor 2 (Nrf2)-mediated Inhibition of NF-κB Signaling Pathway.
Sun CC; Li SJ; Yang CL; Xue RL; Xi YY; Wang L; Zhao QL; Li DJ
J Biol Chem; 2015 Jul; 290(29):17784-17795. PubMed ID: 26013831
[TBL] [Abstract][Full Text] [Related]
8. Sulforaphane Protect Against Cadmium-Induced Oxidative Damage in mouse Leydigs Cells by Activating Nrf2/ARE Signaling Pathway.
Yang SH; Li P; Yu LH; Li L; Long M; Liu MD; He JB
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717178
[TBL] [Abstract][Full Text] [Related]
9. Protection by sulforaphane from type 1 diabetes-induced testicular apoptosis is associated with the up-regulation of Nrf2 expression and function.
Jiang X; Bai Y; Zhang Z; Xin Y; Cai L
Toxicol Appl Pharmacol; 2014 Sep; 279(2):198-210. PubMed ID: 24967692
[TBL] [Abstract][Full Text] [Related]
10. Sulforaphane mitigates muscle fibrosis in mdx mice via Nrf2-mediated inhibition of TGF-β/Smad signaling.
Sun C; Li S; Li D
J Appl Physiol (1985); 2016 Feb; 120(4):377-90. PubMed ID: 26494449
[TBL] [Abstract][Full Text] [Related]
11. Metallothionein plays a prominent role in the prevention of diabetic nephropathy by sulforaphane via up-regulation of Nrf2.
Wu H; Kong L; Cheng Y; Zhang Z; Wang Y; Luo M; Tan Y; Chen X; Miao L; Cai L
Free Radic Biol Med; 2015 Dec; 89():431-42. PubMed ID: 26415026
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of sulforaphane on type 2 diabetes-induced cardiomyopathy via AMPK-mediated activation of lipid metabolic pathways and NRF2 function.
Sun Y; Zhou S; Guo H; Zhang J; Ma T; Zheng Y; Zhang Z; Cai L
Metabolism; 2020 Jan; 102():154002. PubMed ID: 31706979
[TBL] [Abstract][Full Text] [Related]
13. Anti-Inflammatory Effect of Sulforaphane on LPS-Activated Microglia Potentially through JNK/AP-1/NF-κB Inhibition and Nrf2/HO-1 Activation.
Subedi L; Lee JH; Yumnam S; Ji E; Kim SY
Cells; 2019 Feb; 8(2):. PubMed ID: 30813369
[TBL] [Abstract][Full Text] [Related]
14. Sulforaphane Attenuated the Pro-Inflammatory State Induced by Hydrogen Peroxide in SH-SY5Y Cells Through the Nrf2/HO-1 Signaling Pathway.
de Oliveira MR; Brasil FB; Fürstenau CR
Neurotox Res; 2018 Aug; 34(2):241-249. PubMed ID: 29473125
[TBL] [Abstract][Full Text] [Related]
15. Effects of heme oxygenase 1 in the molecular changes and neuropathy associated with type 2 diabetes in mice.
Pouso-Vázquez E; Bai X; Batallé G; Roch G; Pol O
Biochem Pharmacol; 2022 May; 199():114987. PubMed ID: 35276215
[TBL] [Abstract][Full Text] [Related]
16. Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway.
Zhang Z; Wang S; Zhou S; Yan X; Wang Y; Chen J; Mellen N; Kong M; Gu J; Tan Y; Zheng Y; Cai L
J Mol Cell Cardiol; 2014 Dec; 77():42-52. PubMed ID: 25268649
[TBL] [Abstract][Full Text] [Related]
17. Protection against diabetic cardiomyopathy is achieved using a combination of sulforaphane and zinc in type 1 diabetic OVE26 mice.
Wang J; Wang S; Wang W; Chen J; Zhang Z; Zheng Q; Liu Q; Cai L
J Cell Mol Med; 2019 Sep; 23(9):6319-6330. PubMed ID: 31270951
[TBL] [Abstract][Full Text] [Related]
18. Sulforaphane prevents type 2 diabetes-induced nephropathy via AMPK-mediated activation of lipid metabolic pathways and Nrf2 antioxidative function.
Li Z; Guo H; Li J; Ma T; Zhou S; Zhang Z; Miao L; Cai L
Clin Sci (Lond); 2020 Sep; 134(18):2469-2487. PubMed ID: 32940670
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms underlying the perifocal neuroprotective effect of the Nrf2-ARE signaling pathway after intracranial hemorrhage.
Yin XP; Chen ZY; Zhou J; Wu D; Bao B
Drug Des Devel Ther; 2015; 9():5973-86. PubMed ID: 26604696
[TBL] [Abstract][Full Text] [Related]
20. Sulforaphane attenuation of experimental diabetic nephropathy involves GSK-3 beta/Fyn/Nrf2 signaling pathway.
Shang G; Tang X; Gao P; Guo F; Liu H; Zhao Z; Chen Q; Jiang T; Zhang N; Li H
J Nutr Biochem; 2015 Jun; 26(6):596-606. PubMed ID: 25724107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
